De-Linking R&D costs from drug prices and the sustainability of treatment / découpler les coûts de R&D du prix des médicaments | Knowledge Ecology International
http://keionline.org/node/1151
With regard to new medicines for HIV, policymakers need a strategy for making both innovation and universal access feasible. Such a strategy will necessarily involve de-linking R&D costs from drug prices.
et un petit rappel : la #recherche & développement ne pèse pas lourd dans les comptes des #pharma
http://keionline.org/node/1152
http://keionline.org/sites/default/files/u4/sales_rnd_2010_0.png
#prize